Finding Atrial Fibrillation in Stroke - Evaluation of Enhanced and Prolonged Holter Monitoring

Active, not recruiting

Phase N/A Results N/A

Update History

4 Sep '14
A location was updated in Goettingen.
New
The overall status was removed for Dept. of Cardiology and Pneumology, University Medical Center Goettingen.
A location was updated in Mainz.
New
The overall status was removed for Clinic and Policlinic for Neurology, University of Mainz.
A location was updated in Sande.
New
The overall status was removed for Dept. of Neurology, Nordwest-Hospital Sanderbusch.
A location was updated in Wiesbaden.
New
The overall status was removed for Dept. of Neurology, HSK, Dr. Horst-Schmidt-Hospital.
30 Oct '13
The eligibility criteria were updated.
New
Inclusion Criteria: - Recent cerebral ischemia defined as stroke (sudden focal neurologic deficit lasting > 24h consistent with the territory of a major cerebral artery and categorised as ischemic) and/or a corresponding lesion on brain imaging. - Stroke symptoms started ≤ 7 days ago. - Age ≥ 60 years. - Modified Rankin scale ≤ 2 (prior to index event). Exclusion Criteria: - Known history of atrial fibrillation/flutter or atrial fibrillation/flutter on admission ECG. - Indication for oral anticoagulation at randomisation. - Absolute contra-indication against oral anticoagulation at randomisation. - Intracerebral bleeding in medical history. - Patient scheduled for Holter-ECG or cardiac Event-Recording monitoring ≥ 48 hours. - Significant carotid artery or vertebral artery stenosis > 50% (NASCET classification), significant intracranial artery stenosis suspicious of atherosclerotic origin or acute arterial dissection explanatory of stroke symptoms. - Implanted pacemaker device or cardioverter/defibrillator. - Life expectancy < 1 year for reasons other than stroke (e.g. metastatic cancer). - Concomitant participation in other controlled randomised trial.
Old
Inclusion Criteria: - Recent cerebral ischemia defined as stroke (sudden focal neurologic deficit lasting > 24h consistent with the territory of a major cerebral artery and categorised as ischemic) and/or a corresponding lesion on brain imaging. - Stroke symptoms started ≤ 7 days ago. - Age ≥ 60 years. - Modified Rankin scale ≤ 2 (prior to index event). Exclusion Criteria: - Known history of atrial fibrillation/flutter or atrial fibrillation/flutter on admission ECG. - Indication for oral anticoagulation at randomisation. - Absolute contra-indication against oral anticoagulation at randomisation. - Intracerebral bleeding in medical history. - Patient scheduled for Holter-ECG or cardiac Event-Recording monitoring ≥ 48 hours. - Carotid artery stenosis of > 50% (NASCET) needing revascularisation and ipsilateral to ischemic territory. - Implanted pacemaker device or cardioverter/defibrillator. - Life expectancy < 1 year for reasons other than stroke (e.g. metastatic cancer). - Concomitant participation in other controlled randomised trial.
A location was updated in Mainz.
New
The overall status was removed for Clinic and Policlinic for Neurology, University of Mainz.
A location was updated in Wiesbaden.
New
The overall status was removed for Dept. of Neurology, HSK, Dr. Horst-Schmidt-Hospital.